These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Pulmonary involvement in pediatric-onset multisystem Langerhans cell histiocytosis: effect on course and outcome. Ronceray L; Pötschger U; Janka G; Gadner H; Minkov M; J Pediatr; 2012 Jul; 161(1):129-33.e1-3. PubMed ID: 22284564 [TBL] [Abstract][Full Text] [Related]
44. [Langerhans cell histiocytosis in adult patients--a disease with many faces. Experience of a centre and an overview of the disease symptoms]. Adam Z; Pour L; Krejcí M; Neubauer J; Vanícek J; Vasků V; Hájek R Vnitr Lek; 2008 Nov; 54(11):1063-80. PubMed ID: 19069680 [TBL] [Abstract][Full Text] [Related]
45. Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study. Morimoto A; Shioda Y; Imamura T; Kudo K; Kawaguchi H; Sakashita K; Yasui M; Koga Y; Kobayashi R; Ishii E; Fujimoto J; Horibe K; Bessho F; Tsunematsu Y; Imashuku S Int J Hematol; 2016 Jul; 104(1):99-109. PubMed ID: 27040279 [TBL] [Abstract][Full Text] [Related]
47. Improved outcome of refractory Langerhans cell histiocytosis in children with hematopoietic stem cell transplantation in Japan. Kudo K; Ohga S; Morimoto A; Ishida Y; Suzuki N; Hasegawa D; Nagatoshi Y; Kato S; Ishii E Bone Marrow Transplant; 2010 May; 45(5):901-6. PubMed ID: 19767778 [TBL] [Abstract][Full Text] [Related]
48. Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning. Steiner M; Matthes-Martin S; Attarbaschi A; Minkov M; Grois N; Unger E; Holter W; Vormoor J; Wawer A; Ouachee M; Woessmann W; Gadner H Bone Marrow Transplant; 2005 Aug; 36(3):215-25. PubMed ID: 15937510 [TBL] [Abstract][Full Text] [Related]
49. Adult-onset systemic Langerhans cell histiocytosis mimicking inflammatory bowel disease: the value of skin biopsy and review of cases of Langerhans cell histiocytosis with cutaneous involvement seen at the Mayo Clinic. Podjasek JO; Loftus CG; Smyrk TC; Wieland CN Int J Dermatol; 2014 Mar; 53(3):305-11. PubMed ID: 23621577 [TBL] [Abstract][Full Text] [Related]
50. Multisystem langerhans cell histiocytosis with thymic involvement diagnosed with anterior mediastinal mass in a 2-month-old boy. Tekkeşin F; Okur A; Derinkuyu BE; Akyürek N; Oğuz A; Karadeniz C; Pınarlı FG Turk J Pediatr; 2016; 58(4):424-428. PubMed ID: 28276218 [TBL] [Abstract][Full Text] [Related]
52. Analysis of loss of heterozygosity in single-system and multisystem Langerhans' cell histiocytosis. Chikwava KR; Hunt JL; Mantha GS; Murphy JE; Jaffe R Pediatr Dev Pathol; 2007; 10(1):18-24. PubMed ID: 17378622 [TBL] [Abstract][Full Text] [Related]
58. Retrospective study of Langerhans cell histiocytosis in ear, nose and neck. Guo Y; Ning F; Wang G; Li X; Liu J; Yuan Y; Dai P Am J Otolaryngol; 2020; 41(2):102369. PubMed ID: 31870640 [TBL] [Abstract][Full Text] [Related]
60. New clinical score for disease activity at diagnosis in Langerhans cell histiocytosis. Choi WI; Jeong YC; Kim SY; Kim SD; Pribis JP; Kim HJ; Koh KN; Im HJ; Lee YH; Seo JJ Korean J Hematol; 2011 Sep; 46(3):186-91. PubMed ID: 22065974 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]